GH Research (GHRS) News Today → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free GHRS Stock Alerts $10.51 +0.01 (+0.10%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMGB expands effort to make medical research more sustainablebizjournals.com - April 26 at 2:45 AMGH Video Preview: Gregory in Trouble, Joss Tells Jason She Did Something She Regretsmsn.com - April 26 at 2:45 AMGH Research (NASDAQ:GHRS) Shares Up 6.8%marketbeat.com - April 22 at 5:37 PMContrasting GH Research (NASDAQ:GHRS) & ORIC Pharmaceuticals (NASDAQ:ORIC)americanbankingnews.com - April 20 at 2:16 AMGeneral Hospital Video Preview: Is Cyrus the Key to Bringing Down Sonny?yahoo.com - April 18 at 2:38 PMGH Spoilers Weekly Preview Video: It’s Sonny Corinthos Versus the Worldyahoo.com - April 17 at 2:20 PMGH Research (NASDAQ:GHRS) Shares Down 3.1% marketbeat.com - April 17 at 11:58 AMGH Research (NASDAQ:GHRS) Trading Up 2.6%marketbeat.com - April 15 at 5:31 PMGH Research (NASDAQ:GHRS) Trading Down 4.4%marketbeat.com - March 21 at 6:43 PMGH Research (NASDAQ:GHRS) Sees Strong Trading Volumemarketbeat.com - March 20 at 4:31 PMGeneral Hospital Video Preview: Misdirections, Maladies, and Misdiagnosesyahoo.com - March 17 at 8:58 AMGeneral Hospital Video Preview: Catastrophic Thoughts Plague Jason and Sonnyyahoo.com - March 15 at 9:14 AMThe General Hospital Coming Out Storyline Nobody Saw Comingyahoo.com - March 15 at 9:14 AMGH Research (NASDAQ:GHRS) Trading 7.9% Higher marketbeat.com - March 13 at 2:16 PMBuy Rating for GH Research: Promising Clinical Trials and Strategic Intellectual Property Advancesmarkets.businessinsider.com - March 4 at 8:36 PMBuy Rating Justified by GH Research’s Promising Clinical Trials and Strong Financial Healthmarkets.businessinsider.com - March 1 at 9:58 AMGH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updatesmsn.com - March 1 at 12:07 AMGH Research Reports Full Year 2023 Financial Results and Provides Business Updatesglobenewswire.com - February 29 at 7:00 AMGH Research PLC to Post FY2027 Earnings of ($1.10) Per Share, HC Wainwright Forecasts (NASDAQ:GHRS)marketbeat.com - January 22 at 2:23 AMGH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depressionfinance.yahoo.com - January 18 at 5:17 PMCan GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect?finance.yahoo.com - January 16 at 3:04 PMGeneral Hospital Season 61: How Many Episodes & When Do New Episodes Come Out?yahoo.com - January 16 at 10:03 AMGeneral Hospital Season 61 Streaming: Watch & Stream Online via Huluyahoo.com - December 26 at 6:22 PMWe're Hopeful That GH Research (NASDAQ:GHRS) Will Use Its Cash Wiselyfinance.yahoo.com - December 25 at 9:30 AMThese Four Stocks Tap into the Exploding Psychedelic Treatment Marketnasdaq.com - December 20 at 11:19 PMPsyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And Moremsn.com - November 24 at 1:44 PMAnalysts Offer Insights on Technology Companies: Inuvo (INUV) and GH Research (GHRS)markets.businessinsider.com - November 11 at 4:48 AMGH Research Earns ‘Buy’ Rating: Promising Progress, Proactive Approach, and Solid Financial Standingmarkets.businessinsider.com - November 10 at 5:28 PMGH Research PLC: GH Research Reports Third Quarter Financial Results and Provides Business Updatesfinanznachrichten.de - November 10 at 7:27 AMGH Research Reports Third Quarter Financial Results and Provides Business Updatesfinance.yahoo.com - November 9 at 9:27 PMGH Research PLC GHRSmorningstar.com - November 2 at 10:16 AMPositive Outlook for GH Research Despite FDA’s Clinical Hold: An Analysis of GH001’s Trials and Prospectsmarkets.businessinsider.com - October 3 at 3:20 PMGH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Holdbenzinga.com - October 2 at 6:48 PMGH Research PLC: GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depressionfinanznachrichten.de - September 30 at 8:56 AMGH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depressionfinance.yahoo.com - September 29 at 5:28 PMH.C. Wainwright Sticks to Their Buy Rating for GH Research (GHRS)markets.businessinsider.com - August 24 at 6:06 PMGH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026markets.businessinsider.com - August 24 at 6:06 PMGH Research PLC: GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updatesfinanznachrichten.de - August 23 at 9:52 AMGH Research Reports Second Quarter 2023 Financial Results and Provides Business Updatesfinance.yahoo.com - August 23 at 9:52 AMGH Research PLCthestreet.com - August 4 at 3:54 AMHere's Why We're Not Too Worried About GH Research's (NASDAQ:GHRS) Cash Burn Situationfinance.yahoo.com - July 17 at 2:01 PM7 Best Psychedelic Stocks to Watch in 2023msn.com - July 11 at 7:52 PMHC Wainwright & Co. Reiterates Buy on GH Research, Maintains $45 Price Targetbenzinga.com - July 6 at 3:03 PM‘It’s Really a Brain Chemistry Issue’: Elon Musk Embraces Ketamine in the Battle Against Depression — Here Are 2 Psychedelic Stocks That Analysts Likefinance.yahoo.com - July 6 at 10:02 AMLawrence General Hospitalhealth.usnews.com - June 30 at 11:19 PMGH Research: But Toad Venom Is A Controlled Substanceseekingalpha.com - June 16 at 11:06 AMMirae Asset Global Investments Co. Ltd. Sells 20,167 Shares of GH Research PLC (NASDAQ:GHRS)marketbeat.com - May 30 at 5:29 AMFY2027 EPS Estimates for GH Research PLC Increased by HC Wainwright (NASDAQ:GHRS)marketbeat.com - May 15 at 4:38 AMJMP Securities Maintains GH Research (GHRS) Outperform Recommendationmsn.com - May 12 at 4:24 PMHC Wainwright & Co. Reiterates GH Research (GHRS) Buy Recommendationmsn.com - May 12 at 4:24 PM Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. GHRS Media Mentions By Week GHRS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GHRS News Sentiment▼-0.200.33▲Average Medical News Sentiment GHRS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GHRS Articles This Week▼51▲GHRS Articles Average Week Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AnaptysBio News ArriVent BioPharma News Phathom Pharmaceuticals News Korro Bio News CureVac News Verve Therapeutics News Applied Therapeutics News Mineralys Therapeutics News COMPASS Pathways News IGM Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GHRS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
